Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: A potential predictive biomarker for high risk of Eczema herpeticum

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 11, 2015, Pages 1432-1439

  Staudacher, A ^a   Hinz, T ^a   Novak, N ^a   Von Bubnoff, D ^b   Bieber, T ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

atopic dermatitis; biomarker; Eczema herpeticum; herpes simplex virus; indoleamine 2,3 dioxygenase; Langerhans cells

Indexed keywords

BIOLOGICAL MARKER; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN;

ADULT; ARTICLE; ATOPIC DERMATITIS; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KAPOSI VARICELLIFORM ERUPTION; LANGERHANS CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MONOCYTE; PATHOPHYSIOLOGY; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SERUM; SUPERNATANT; VIRUS ACTIVATION; YOUNG ADULT; COMPLICATION; DENDRITIC CELL; DERMATITIS, ATOPIC; DISEASE COURSE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; SIMPLEXVIRUS;

ADULT; BIOMARKERS; DENDRITIC CELLS; DERMATITIS, ATOPIC; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KAPOSI VARICELLIFORM ERUPTION; LANGERHANS CELLS; MALE; MIDDLE AGED; MONOCYTES; SIMPLEXVIRUS; TRYPTOPHAN; YOUNG ADULT;

EID: 84945483552     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12699     Document Type: Article

References (48)

1. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
2. Eyerich K, Novak N,. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 2013; 68: 974-982.
3. Howell MD, Parker ML, Mustelin T, Ranade K,. Past, present, and future for biologic intervention in atopic dermatitis. Allergy 2015; 70: 887-896.
4. Bieber T, Straeter B,. Off-label prescriptions for atopic dermatitis in Europe. Allergy 2015; 70: 6-11.
5. Simon D, Bieber T,. Systemic therapy for atopic dermatitis. Allergy 2014; 69: 46-55.
6. Hinz T, Zaccaro D, Byron M, Brendes K, Krieg T, Novak N, et al., Atopic dermo-respiratory syndrome is a correlate of eczema herpeticum. Allergy 2011; 66: 925-933.
7. Wollenberg A,. Eczema herpeticum. Chem Immunol Allergy 2012; 96: 89-95.
8. Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B,. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol 2003; 49: 198-205.
9. Peng WM, Jenneck C, Bussmann C, Bogdanow M, Hart J, Leung DY, et al., Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol 2007; 127: 1261-1263.
10. Gao PS, Rafaels NM, Hand T, Murray T, Boguniewicz M, Hata T, et al., Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol 2009; 124: 507-513, 513.
11. Leung DY, Gao PS, Grigoryev DN, Rafaels NM, Streib JE, Howell MD, et al., Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response. J Allergy Clin Immunol 2011; 127: 965-973.
12. Barchet W, Cella M, Colonna M,. Plasmacytoid dendritic cells-virus experts of innate immunity. Semin Immunol 2005; 17: 253-261.
13. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, et al., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5: 919-923.
14. Wollenberg A, Wagner M, Gunther S, Towarowski A, Tuma E, Moderer M, et al., Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002; 119: 1096-1102.
15. Huch JH, Cunningham AL, Arvin AM, Nasr N, Santegoets SJ, Slobedman E, et al., Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J Virol 2010; 84: 4060-4072.
16. Cunningham AL, Abendroth A, Jones C, Nasr N, Turville S,. Viruses and Langerhans cells. Immunol Cell Biol 2010; 88: 416-423.
17. Bosnjak L, Jones CA, Abendroth A, Cunningham AL,. Dendritic cell biology in herpesvirus infections. Viral Immunol 2005; 18: 419-433.
18. Ball HJ, Jusof FF, Bakmiwewa SM, Hunt NH, Yuasa HJ,. Tryptophan-catabolizing enzymes-party of three. Front Immunol 2014; 5: 485.
19. Munn DH, Mellor AL,. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 2013; 34: 137-143.
20. Fallarino F, Grohmann U, Puccetti P,. Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur J Immunol 2012; 42: 1932-1937.
21. Harden JL, Egilmez NK,. Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest 2012; 41: 738-764.
22. Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, et al., HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007; 109: 3351-3359.
23. von Bubnoff D, Bausinger H, Matz H, Koch S, Hacker G, Takikawa O, et al., Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. J Invest Dermatol 2004; 123: 298-304.
24. Fallarino F, Puccetti P,. Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism. Eur J Immunol 2006; 36: 8-11.
25. MacKenzie CR, Heseler K, Muller A, Daubener W,. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr Drug Metab 2007; 8: 237-244.
26. Meisel R, Brockers S, Heseler K, Degistirici O, Bulle H, Woite C, et al., Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 2011; 25: 648-654.
27. Schmidt SK, Ebel S, Keil E, Woite C, Ernst JF, Benzin AE, et al., Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions. PLoS ONE 2013; 8: e63301.
28. Nino-Castro A, Abdullah Z, Popov A, Thabet Y, Beyer M, Knolle P, et al., The IDO1-induced kynurenines play a major role in the antimicrobial effect of human myeloid cells against Listeria monocytogenes. Innate Immun 2014; 20: 401-411.
29. Narui K, Noguchi N, Saito A, Kakimi K, Motomura N, Kubo K, et al., Anti-infectious activity of tryptophan metabolites in the L-tryptophan-L-kynurenine pathway. Biol Pharm Bull 2009; 32: 41-44.
30. Muller A, Heseler K, Schmidt SK, Spekker K, Mackenzie CR, Daubener W,. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med 2009; 13: 1125-1135.
31. Schmidt SV, Schultze JL,. New insights into IDO biology in bacterial and viral infections. Front Immunol 2014; 5: 384.
32. Adams O, Besken K, Oberdorfer C, MacKenzie CR, Russing D, Daubener W,. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect 2004; 6: 806-812.
33. Liu WL, Lin YH, Xiao H, Xing S, Chen H, Chi PD, et al., Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-kappaB pathways: impairment in T cell functions. J Virol 2014; 88: 6660-6671.
34. Meisel R, Heseler K, Nau J, Schmidt SK, Leineweber M, Pudelko S, et al., Cytomegalovirus infection impairs immunosuppressive and antimicrobial effector functions of human multipotent mesenchymal stromal cells. Mediators Inflamm 2014; 2014: 898630.
35. von Bubnoff D, Fimmers R, Bogdanow M, Matz H, Koch S, Bieber T,. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 2004; 34: 1056-1063.
36. Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ,. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol 2010; 126: 754-762.
37. Kawasaki H, Chang HW, Tseng HC, Hsu SC, Yang SJ, Hung CH, et al., A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor. Allergy 2014; 69: 445-452.
38. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, et al., Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 2011; 12: 870-878.
39. Von Bubnoff D, Scheler M, Wilms H, Fimmers R, Bieber T,. Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli. J Immunol 2011; 186: 6701-6709.
40. Novak N, Bieber T, Katoh N,. Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol 2001; 167: 797-804.
41. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O,. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998; 187: 961-966.
42. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, et al., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27: 3135-3142.
43. Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M,. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy. Mol Immunol 2006; 43: 1054-1056.
44. Larrea E, Riezu-Boj JI, Gil-Guerrero L, Casares N, Aldabe R, Sarobe P, et al., Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection. J Virol 2007; 81: 3662-3666.
45. Boasso A, Royle CM, Doumazos S, Aquino VN, Biasin M, Piacentini L, et al., Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis. Blood 2011; 118: 5152-5162.
46. Coutinho LG, Christen S, Bellac CL, Fontes F, de Souza F, Grandgirard D, et al., The kynurenine pathway is involved in bacterial meningitis. J Neuroinflammation 2014; 11: 169.
47. de Souza FR, Fontes FL, da Silva TA, Coutinho LG, Leib SL, Agnez-Lima LF,. Association of kynurenine aminotransferase II gene C401T polymorphism with immune response in patients with meningitis. BMC Med Genet 2011; 12: 51.
48. Xue ZT, Sjogren HO, Salford LG, Widegren B,. An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-gamma: potential therapeutic use in autoimmune diseases. Mol Immunol 2012; 51: 101-111.